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COMMENTS
We fully agree with the review authors' conclusions 1 that there is no proof in the literature that TMLR has clinical benefits that outweigh the potential risks. Like in the Vineberg procedure in the past, the distal perfusion through the microcirculation can be quite variable from patient to patient and intramyocardial hematomas may result, with serious consequences.
The more sophisticated techniques of epicardial myocardial revascularization, using internal thoracic arteries in sequential anastomosis to two or even three coronary arteries, or using saphenous veins in bypasses to reach truly distal portions of diseased arteries, and the use of other arterial conduits, usually eliminates angina in patients with good enough myocardial function. For patients with extremely severe and diffuse coronary artery disease or bad ventricular function, heart transplantation should be considered. 
